Nishio Y, Warren C E, Buczek-Thomas J A, Rulfs J, Koya D, Aiello L P, Feener E P, Miller T B, Dennis J W, King G L
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
J Clin Invest. 1995 Oct;96(4):1759-67. doi: 10.1172/JCI118221.
Primary cardiac abnormalities have been frequently reported in patients with diabetes probably due to metabolic consequences of the disease. Approximately 2,000 mRNA species from the heart of streptozotocin-induced diabetic and control rats were compared by the mRNA differential display method, two of eight candidate clones thus isolated (DH1 and 13) were confirmed by Northern blot analysis. The expression of clone 13 was increased in the heart by 3.5-fold (P < 0.05) and decreased in the aorta by twofold (P < 0.05) in diabetes as compared to control. Sequence analysis showed that clone 13 is a rat mitochondrial gene. DH1 was predominantly expressed in the heart with an expression level 6.8-fold higher in the diabetic rats than in control (P < 0.001). Insulin treatment significantly (P < 0.001) normalized the expression of DH1 in the hearts of diabetic rats. DH1 expression was observed in cultured rat cardiomyocytes, but not in aortic smooth muscle cells or in cardiac derived fibroblasts. The expression in cardiomyocytes was regulated by insulin and glucose concentration of culture media. The full length cDNA of DH1 had a single open-reading frame with 85 and 92% amino acid identity to human and mouse UDP-GlcNAc:Gal beta 1-3GalNAc alpha R beta 1-6 N-acetylglucosaminyltransferase (core 2 GlcNAc-T), respectively, a key enzyme determining the structure of O-linked glycosylation. Transient transfection of DH1 cDNA into Cos7 cells conferred core 2 GlcNAc-T enzyme activity. In vivo, core 2 GlcNAc-T activity was increased by 82% (P < 0.05) in diabetic hearts vs controls, while the enzymes GlcNAc-TI and GlcNAc-TV responsible for N-linked glycosylation were unchanged. These results suggest that core 2 GlcNAc-T is specifically induced in the heart by diabetes or hyperglycemia. The induction of this enzyme may be responsible for the increase in the deposition of glycoconjugates and the abnormal functions found in the hearts of diabetic rats.
原发性心脏异常在糖尿病患者中屡有报道,这可能是该疾病的代谢后果所致。采用mRNA差异显示法比较了链脲佐菌素诱导的糖尿病大鼠和对照大鼠心脏中约2000种mRNA,通过Northern印迹分析证实了由此分离出的8个候选克隆中的2个(DH1和13)。与对照相比,糖尿病时克隆13在心脏中的表达增加了3.5倍(P<0.05),在主动脉中的表达降低了两倍(P<0.05)。序列分析表明克隆13是大鼠线粒体基因。DH1主要在心脏中表达,糖尿病大鼠中的表达水平比对照高6.8倍(P<0.001)。胰岛素治疗显著(P<0.001)使糖尿病大鼠心脏中DH1的表达恢复正常。在培养的大鼠心肌细胞中观察到DH1的表达,但在主动脉平滑肌细胞或心脏来源的成纤维细胞中未观察到。心肌细胞中的表达受培养基中胰岛素和葡萄糖浓度的调节。DH1的全长cDNA有一个单一的开放阅读框,与人及小鼠的UDP-GlcNAc:Galβ1-3GalNAcαRβ1-6N-乙酰葡糖胺基转移酶(核心2GlcNAc-T)的氨基酸同一性分别为85%和92%,该酶是决定O-连接糖基化结构的关键酶。将DH1 cDNA瞬时转染到Cos7细胞中赋予了核心2GlcNAc-T酶活性。在体内,与对照相比,糖尿病心脏中核心2GlcNAc-T活性增加了82%(P<0.05),而负责N-连接糖基化的酶GlcNAc-TI和GlcNAc-TV未改变。这些结果表明,糖尿病或高血糖症可特异性诱导心脏中的核心2GlcNAc-T。该酶的诱导可能是糖尿病大鼠心脏中糖缀合物沉积增加和功能异常的原因。